Health Canada Grants Authorization for Leqembi® (lecanemab)
Go back to Health Canada Grants Authorization for Leqembi® (lecanemab)| BARNES GROUP, Inc. (NYSE: B) | Delayed: 38.14 -0.51 (1.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $38.65 | 52 Week High | $44.27 | |||
| Open | $38.34 | 52 Week Low | $30.07 | |||
| Day High | $38.59 | P/E | 29.11 | |||
| Day Low | $37.40 | EPS | $1.31 | |||
| Volume | 6,873,539 | |||||
| BIOAMBER, Inc. (NASDAQ: BIOA) | Delayed: 5.10 -0.43 (7.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.53 | 52 Week High | $8.73 | |||
| Open | $5.48 | 52 Week Low | $2.86 | |||
| Day High | $5.48 | P/E | N/A | |||
| Day Low | $5.05 | EPS | $-3.82 | |||
| Volume | 465,875 | |||||



